Published in Acta Neurobiol Exp (Wars) on January 01, 2013
Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System. J Stem Cell Res Ther (2015) 0.77
Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ Health Perspect (2007) 1.26
Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX (2011) 1.02
In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Neurotoxicology (2009) 0.96
Micro-stamped surfaces for the patterned growth of neural stem cells. Biomaterials (2008) 0.94
Neural stem-like cell line derived from a nonhematopoietic population of human umbilical cord blood. Stem Cells Dev (2006) 0.94
Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood. Stem Cells (2005) 0.91
Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct. Stem Cells Dev (2007) 0.90
Diazepam neuroprotection in excitotoxic and oxidative stress involves a mitochondrial mechanism additional to the GABAAR and hypothermic effects. Neurochem Int (2009) 0.90
Generation of functional neural artificial tissue from human umbilical cord blood stem cells. Tissue Eng Part C Methods (2009) 0.89
A novel, neural potential of non-hematopoietic human umbilical cord blood stem cells. Int J Dev Biol (2008) 0.88
Influence of low oxygen tensions on expression of pluripotency genes in stem cells. Acta Neurobiol Exp (Wars) (2011) 0.87
Opposite reaction of ERK and JNK in ischemia vulnerable and resistant regions of hippocampus: involvement of mitochondria. Brain Res Mol Brain Res (2003) 0.85
HAX-1 is a nucleocytoplasmic shuttling protein with a possible role in mRNA processing. FEBS J (2012) 0.85
Neuronal differentiation of human umbilical cord blood neural stem-like cell line. Neurodegener Dis (2006) 0.84
Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered. Neurotoxicol Teratol (2008) 0.83
Involvement of MMPs in delayed neuronal death after global ischemia. Acta Neurobiol Exp (Wars) (2002) 0.82
Differentiation of glia-committed NG2 cells: the role of factors released from hippocampus and spinal cord. Acta Neurobiol Exp (Wars) (2013) 0.80
Transient forebrain ischemia modulates signal transduction from extracellular matrix in gerbil hippocampus. Brain Res (2003) 0.79
Transient forebrain ischemia effects interaction of Src, FAK, and PYK2 with the NR2B subunit of N-methyl-D-aspartate receptor in gerbil hippocampus. Brain Res (2005) 0.79
Patterned growth and differentiation of human cord blood-derived neural stem cells on bio-functionalized surfaces. Acta Neurobiol Exp (Wars) (2009) 0.79
Rabbit paralytic tremor phenotype--a plp1 gene mutation as a model of human Pelizaeus-Merzbacher disease. Acta Neurobiol Exp (Wars) (2005) 0.79
AP2-like cis element is required for calretinin gene promoter activity in cells of neuronal phenotype differentiated from multipotent human cell line DEV. Biochim Biophys Acta (2002) 0.79
Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood. Acta Neurobiol Exp (Wars) (2012) 0.78
PKC and Raf-1 inhibition-related apoptotic signalling in N2a cells. J Neurochem (2002) 0.77
Bilateral interaction between cord blood-derived human neural stem cells and organotypic rat hippocampal culture. Stem Cells Dev (2009) 0.77
Patterning of human cord blood-derived stem cells on single cell posts and lines: Implications for neural commitment. Acta Neurobiol Exp (Wars) (2012) 0.77
Housing conditions influence motor functions and exploratory behavior following focal damage of the rat brain. Acta Neurobiol Exp (Wars) (2009) 0.76
Laminin promotes oligogliogenesis and increases MMPs activity in human neural stem cells of HUCB-NSC line. Acta Neurobiol Exp (Wars) (2009) 0.76
Reprogramming of somatic cells: possible methods to derive safe, clinical-grade human induced pluripotent stem cells. Acta Neurobiol Exp (Wars) (2014) 0.75
Proliferation capacity of cord blood derived neural stem cell line on different micro-scale biofunctional domains. Acta Neurobiol Exp (Wars) (2011) 0.75
[Bioengineering of neural stem cell niche]. Postepy Biochem (2013) 0.75
Functional properties of different collagen scaffolds to create a biomimetic niche for neurally committed human induced pluripotent stem cells (iPSC). Folia Neuropathol (2017) 0.75
Phenotypic diversity resulting from a point mutation. Folia Neuropathol (2006) 0.75
Microcontact printing and microspotting as methods for direct protein patterning on plasma deposited polyethylene oxide: application to stem cell patterning. Biomed Microdevices (2013) 0.75
[Stem cells--potential therapeutic use in neurological diseases]. Neurol Neurochir Pol (2002) 0.75